Medicare Enrolled

Dr. Dominic Sreshta, M.D.

Hospice and Palliative Medicine (Internal Medicine) Physician · Sugar Land, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
16701 CREEK BEND DR # 500, Sugar Land, TX 77478
2812650409
In practice since 2005 (20 years)
NPI: 1760486179 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sreshta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sreshta? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sreshta

Dr. Dominic Sreshta is a hospice and palliative medicine (internal medicine) physician in Sugar Land, TX, with 20 years in practice. Based on federal Medicare data, Dr. Sreshta performed 1,153 Medicare services across 316 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sreshta received a total of $15,237 from 54 pharmaceutical and/or device companies across 482 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hospice and palliative medicine (internal medicine) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sreshta is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 12% volume in TX$ $15,237 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,153
Medicare services
Top 12% in TX for hospice and palliative medicine (internal medicine) physician
316
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~58 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity640$86$200
Hospital follow-up visit, moderate complexity219$56$125
Office visit, established patient, complex (40-54 min)105$121$300
Initial hospital admission, moderate complexity74$93$200
Office visit, established patient (30-39 min)54$76$250
Assessment of emotional or behavioral problems24$3$15
Test to measure expiratory airflow and volume19$17$45
Annual wellness visit, follow-up18$117$205
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,237
Total received (2018-2024)
Avg $2,177/year across 7 years
Top 2% in TX for hospice and palliative medicine (internal medicine) physician
54
Companies
482
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,097 (53.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,140 (46.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$809
2023
$567
2022
$974
2021
$1,708
2020
$4,052
2019
$4,408
2018
$2,720

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Allergan, Inc.
$4,327
Allergan Inc.
$2,837
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$2,139
Paratek Pharmaceuticals, Inc.
$979
Medtronic, Inc.
$784
Sunovion Pharmaceuticals Inc.
$662
Merck Sharp & Dohme LLC
$356
UROVANT SCIENCES INC
$187
PFIZER INC.
$184
Janssen Pharmaceuticals, Inc
$178
Amgen Inc.
$177
Novartis Pharmaceuticals Corporation
$172
GlaxoSmithKline, LLC.
$171
E.R. Squibb & Sons, L.L.C.
$151
Melinta Therapeutics, Inc.
$145
Mylan Specialty L.P.
$143
Teva Pharmaceuticals USA, Inc.
$120
SUN PHARMACEUTICAL INDUSTRIES INC.
$115
PORTOLA PHARMACEUTICALS, INC.
$96
Corium, LLC
$90
Exact Sciences Corporation
$90
Astellas Pharma US Inc
$88
AbbVie Inc.
$85
Mannkind Corporation
$75
ABBVIE INC.
$58
Marinus Pharmaceuticals, Inc.
$54
Merck Sharp & Dohme Corporation
$49
Biogen, Inc.
$46
Lilly USA, LLC
$46
Inspire Medical Systems, Inc.
$44
ACADIA Pharmaceuticals Inc
$44
Kowa Pharmaceuticals America, Inc.
$42
Shionogi Inc
$34
VIVUS, Inc.
$33
Amarin Pharma Inc.
$32
Inari Medical, Inc.
$29
TOPCON HEALTHCARE SOLUTIONS, INC.
$29
AstraZeneca Pharmaceuticals LP
$27
Medtronic MiniMed, Inc.
$26
MannKind Corporation
$26
Purdue Pharma L.P.
$24
JAZZ PHARMACEUTICALS INC.
$24
Alexion Pharmaceuticals, Inc.
$24
Boston Scientific Corporation
$23
Sumitomo Pharma America, Inc.
$23
Shire North American Group Inc
$23
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$21
Avanir Pharmaceuticals, Inc.
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Biohaven Pharmaceuticals, Inc.
$15
Novo Nordisk Inc
$14
INSYS Therapeutics Inc
$12
Philips Electronics North America Corporation
$12
SANOFI-AVENTIS U.S. LLC
$12
Top 3 companies account for 61.1% of total payments
Associated products mentioned in payments ›
AFREZZA · ANORO · APTIOM · AUSTEDO · AVYCAZ · Adlarity · BEVYXXA · Baxdela · CAMZYOS · CAPLYTA · COLOGUARD DNA CAPTURE REAGENTS · CYCLOSET · Cologuard Collection Kit · DALVANCE · DIFICID · ELIQUIS · ENTRESTO · EPIDIOLEX · FLECTOR · FLOWTRIEVER CATHETER · GATTEX · GEMTESA · HARMONY · INPEN SMART INSULIN DELIVERY SYSTEM · INSPIRE · InPen · JARDIANCE · KAPSPARGO · LONHALA MAGNAIR · LUCEMYRA · LYRICA · Livalo · MINIMED 770G · MOUNJARO · MOVANTIK · MYRBETRIQ · NUEDEXTA · NUPLAZID · NURTEC ODT · NUZYRA · Otezla · QSYMIA · RELISTOR · RELISTOR ORAL · Repatha · Respiratoriy Care Undiv · S · SEEBRI · SEGLENTIS · SIVEXTRO · SKYCLARYS · SYMPROIC · SYNDROS · Symproic · TEFLARO · TOUJEO · TRELEGY ELLIPTA · UBRELVY · ULTOMIRIS · Utibron · VERQUVO · Vascepa · WATCHMAN · Wegovy · XARELTO · XIFAXAN · XIFAXANIBSD · Yupelri · ZTALMY · iPro2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (53%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for hospice and palliative medicine (internal medicine) physician in TX.

Equivalent to $1,321 per 100 Medicare services performed
Looking for a hospice and palliative medicine (internal medicine) physician in Sugar Land?
Compare hospice and palliative medicine (internal medicine) physicians in the Sugar Land area by procedure volume, costs, and industry payment transparency.
Browse hospice and palliative medicine (internal medicine) physicians nearby

Geographic Context

Hospice and Palliative Medicine (Internal Medicine) Physicians within 10 mi
28
Per 100K population
3.3
County median income
$113,409
Nearest hospital
ST LUKE'S SUGAR LAND HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sreshta is a mixed practice specialist, with above-average Medicare volume (top 12% in TX), and high industry engagement (low-engagement, top 2%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sreshta experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Sreshta performed 640 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sreshta receive payments from pharmaceutical companies?
Yes. Dr. Sreshta received a total of $15,237 from 54 companies across 482 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sreshta's costs compare to other hospice and palliative medicine (internal medicine) physicians in Sugar Land?
Dr. Sreshta's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sreshta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →